bibliographic entry 8105547 [be/8105547]
https://w3id.org/oc/corpus/be/8105547

is a
content
  • Lau IJ, Smith D, Aitchison R, Blesing N, Roberts P, Peniket A et al. Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide. Ann Hematol 2015; 94: 643–649. PMID: 25345871
references